Skip Navigation

Phase II Randomized Trial Combining TG01 Vaccine / QS-21 Stimulon With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer TESLA

Brief Summary

Type:
Pancreatic

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05638698

Study #:
STUDY00149222

Start Date:
Dec 14, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05638698

View Complete Trial Details & Eligibility at ClinicalTrials.gov